Israel’s Omnix Medical (reported here previously( is developing novel antibiotic agents for the treatment of hospital-acquired infections involving resistant bacteria. Omnix has successfully completed lab testing and has now raised funding to allow it to commence human clinical trials. https://www.calcalistech.com/ctech/articles/0,7340,L-3868294,00.html … Continue reading →

Israeli biotech Mileutis has developed Imilac – designed to treat mastitis in cows by boosting their immune systems. Imilac is near the marketing stage and can replace the wide use of antibiotics for which resistance is growing and being passed … Continue reading →

Researchers at the Hebrew University of Jerusalem have developed an intravenous injection to fight hospital superbugs (bacteria resistant to most current antibiotics). They used nanotechnology to develop an injected form of mupirocin – which previously was just an antibiotic ointment. … Continue reading →

Israel’s Regina Barzilay co-led an MIT team that used artificial intelligence to discover Halicin – the first entirely new antibiotic molecule in 30 years. It kills two of the most dangerous and durable bacteria which (unlike with other antibiotics) were … Continue reading →

I reported previously (23rd Feb) on the AI system devised at Israel’s Technion for identifying the right antibiotic and dose for curing an individual’s infection. Now, thanks to the KSM Institute of Israel’s Maccabi Health company, the system is getting … Continue reading →

I’ve reported previously (see here) on the many Israeli innovations that are trying to prevent antibiotics from becoming ineffective. Now Israeli startup Nanosynex offers a 4-hour test to determine which antibiotic will be effective and what dose to use to … Continue reading →

Researchers from Israel’s Technion Institute have devised a system for measuring the effectiveness of a combination of antibiotics in fighting infection. https://www.technion.ac.il/en/2019/01/integrated-attack/ https://www.nature.com/articles/s41564-018-0252-1

I reported previously (see here) on Israel’s MeMed which has developed ImmunoXpert – a fast test to determine whether an infection is bacterial or virus. ImmunoXpert is now EU approved and a recent study shows it can reduce unnecessary antibiotic … Continue reading →

Israel’s Team Prismatix – combining scientists at Israel’s Technion Institute and Bnai Zion Medical Center – has won a Discovery Award for its research into rapid diagnostics for antibiotic resistance. The awards are part of the UK Nesta Foundation’s Longitude … Continue reading →

Hebrew University researchers are working on preventing the creation of antibiotic-resistant bacteria. They are analyzing the concentrations of antibiotics and their timescales for destroying bacteria, to optimize treatment regimens and avoid the under / over-treatment of infections. https://www.youtube.com/embed/KaxB3bHuKUY?rel=0